[TLX] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Jun-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -101.99%
YoY- -307.87%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/06/18 31/12/17 30/06/17 31/01/17 30/06/16 31/12/15 CAGR
Revenue 195 0 49 0 0 0 0 -
PBT -10,524 -5,190 -4,806 -3,143 -1,594 1,550 -66 441.43%
Tax 1,884 0 0 0 -38 24 0 -
NP -8,640 -5,190 -4,806 -3,143 -1,556 1,512 -66 407.00%
Tax Rate - - - - - -1.54% - -
Total Cost 8,835 5,190 4,854 3,143 1,556 -1,512 66 410.78%
Ratio Analysis
31/12/18 30/06/18 31/12/17 30/06/17 31/01/17 30/06/16 31/12/15 CAGR
NP Margin -4,430.77 0.00 -9,850.62 0.00 0.00 0.00 0.00 -
Per Share
31/12/18 30/06/18 31/12/17 30/06/17 31/01/17 30/06/16 31/12/15 CAGR
EPS -0.04 -0.03 -0.02 -0.02 -0.01 0.01 -0.00 -
EPS Diluted -0.04 -0.03 -0.02 -0.02 -0.01 0.01 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.